BioScience Trends:杨文明教授团队发现疏风解毒胶囊对SARS-CoV-2奥密克戎感染轻度患者有效

2022-07-13 MedSci原创 MedSci原创

安徽中医药大学第一附属医院的杨文明教授研究团队在国际期刊《生物科学趋势》(BioScience Trends)发表题为“中药疏风解毒胶囊治疗SARS-CoV-2奥密克戎变异毒株感染患者&r

安徽中医药大学第一附属医院的杨文明教授研究团队在国际期刊《生物科学趋势》(BioScience Trends)发表题为“中药疏风解毒胶囊治疗SARS-CoV-2奥密克戎变异毒株感染患者”的最新研究成果。

据悉,该文章是目前为止国际上首篇关于中医药治疗奥密克戎变异毒株引起的新冠肺炎患者并被SCI收录的文章。

该研究是一项开放、随机对照试验研究,先后观察了240例患者以评估疏风解毒胶囊治疗奥密克戎感染者的临床有效性和安全性。对照组患者接受支持性护理,试验组患者在此基础上加用疏风解毒胶囊治疗,为期7天。

重点观察患者咽痛、咳嗽、乏力和发热等症状的恢复,及核酸阴转状况,并记录出现的不良事件的频率和程度,以评估患者用药的安全性。结果显示,疏风解毒胶囊可显著缩短患者核酸转阴时间和总症状改善时间。与对照组比较,总症状改善时间缩短1天,咽痛症状缩短1.9天,咳嗽症状缩短1.1天,乏力症状缩短1.2天,核酸转阴时间缩短0.5天。治疗组的临床治愈率提高了12.8%。

疏风解毒胶囊由虎杖、连翘、板蓝根、柴胡、败酱草、马鞭草、芦根和甘草八味中药组成。该药先后荣获国家专利金奖、中华中医药学会科学技术奖一等奖、安徽省科学技术奖一等奖等。作为治疗急性上呼吸道感染药物,在缓解新冠肺炎患者的发热、乏力和咳嗽方面有显著疗效。

原始出处:

Zhang J, Liu LL, Zhang GL, Li MQ, Ma BT, Yang WM.Treating patients infected with the SARS-CoV-2 Omicron variant with a traditional Chinese medicine, Shufeng Jiedu capsule.BioScience Trends. 2022;16(3):238-241. (DOI: 10.5582/bst.2022.01220)

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (12)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1938109, encodeId=b5b11938109f7, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15902, encryptionId=02de15902d3, topicName=SARS-CoV)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6ab940, createdName=hukaixun, createdTime=Fri Mar 03 20:10:25 CST 2023, time=2023-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1919463, encodeId=29fb1919463e2, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Mon Dec 05 18:10:25 CST 2022, time=2022-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1785300, encodeId=c85a1e8530038, content=<a href='/topic/show?id=51906e79a6' target=_blank style='color:#2F92EE;'>#ENDS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6779, encryptionId=51906e79a6, topicName=ENDS)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82ba2500166, createdName=ms1467340776200723, createdTime=Mon Sep 19 17:10:25 CST 2022, time=2022-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1905728, encodeId=800e1905e2857, content=<a href='/topic/show?id=2ebd1e7981a' target=_blank style='color:#2F92EE;'>#trend#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17798, encryptionId=2ebd1e7981a, topicName=trend)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ced3193, createdName=freve, createdTime=Wed Apr 12 01:10:25 CST 2023, time=2023-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1321380, encodeId=49b81321380dc, content=<a href='/topic/show?id=ac0d159007f' target=_blank style='color:#2F92EE;'>#SARS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15900, encryptionId=ac0d159007f, topicName=SARS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8306486, createdName=小刀医生, createdTime=Thu Jul 14 20:10:25 CST 2022, time=2022-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1376481, encodeId=f57d13e648111, content=<a href='/topic/show?id=2949159989d' target=_blank style='color:#2F92EE;'>#SCIE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15998, encryptionId=2949159989d, topicName=SCIE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17a3387, createdName=jichang, createdTime=Thu Jul 14 20:10:25 CST 2022, time=2022-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232187, encodeId=1cb5123218ec9, content=研究结果和对照组相比不存在显著差异。轻度新冠本身症状就轻微,缓解速度快,存在自限性,也已无需住院治疗,再考虑到患者的个体差异(体质、年龄、疫苗接种情况等)该研究结果的临床症状改善并没有说服力。且对于疗效最显著的咽痛也并非新冠最典型、危害最大的评价监测指标,缺乏最关键的发热(退烧)症状的评价结果(临床单用柴胡、板蓝根退烧作用有限),另外,核酸转阴0.5天(12h)是如何精准评价的?有什么现实意义呢?好奇这么漏洞百出的研究结果是怎么被SCI收录的?, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=821f2227826, createdName=DR.Fu SIR, createdTime=Wed Jul 13 09:36:30 CST 2022, time=2022-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232178, encodeId=8e0512321e856, content=认真学习~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cfb41991958, createdName=xulv123, createdTime=Wed Jul 13 08:51:02 CST 2022, time=2022-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232161, encodeId=3547123216120, content=<a href='/topic/show?id=5c1d22423c8' target=_blank style='color:#2F92EE;'>#中药#</a>治疗<a href='/topic/show?id=65b05806579' target=_blank style='color:#2F92EE;'>#新冠病毒#</a>感染, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22423, encryptionId=5c1d22423c8, topicName=中药), TopicDto(id=58065, encryptionId=65b05806579, topicName=新冠病毒)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=小小医者, createdTime=Wed Jul 13 05:25:33 CST 2022, time=2022-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232160, encodeId=8f95123216049, content=这个研究表明,轻中度的<a href='/topic/show?id=8a4e10443423' target=_blank style='color:#2F92EE;'>#奥密克戎#</a>不用药,同样可以治愈。基本是1周,80%自动康复,治疗约5天,不治疗约6-7天就恢复正常了。部分人,可能需要1-2周时间。 用了中药以后,可能略略感觉好一点。 当然,这个研究设计还是漏洞百出,结论也说明不了太多问题,不过,整个数据还是相对可信的。, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104434, encryptionId=8a4e10443423, topicName=奥密克戎)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=小小医者, createdTime=Wed Jul 13 05:25:17 CST 2022, time=2022-07-13, status=1, ipAttribution=)]
    2023-03-03 hukaixun
  2. [GetPortalCommentsPageByObjectIdResponse(id=1938109, encodeId=b5b11938109f7, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15902, encryptionId=02de15902d3, topicName=SARS-CoV)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6ab940, createdName=hukaixun, createdTime=Fri Mar 03 20:10:25 CST 2023, time=2023-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1919463, encodeId=29fb1919463e2, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Mon Dec 05 18:10:25 CST 2022, time=2022-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1785300, encodeId=c85a1e8530038, content=<a href='/topic/show?id=51906e79a6' target=_blank style='color:#2F92EE;'>#ENDS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6779, encryptionId=51906e79a6, topicName=ENDS)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82ba2500166, createdName=ms1467340776200723, createdTime=Mon Sep 19 17:10:25 CST 2022, time=2022-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1905728, encodeId=800e1905e2857, content=<a href='/topic/show?id=2ebd1e7981a' target=_blank style='color:#2F92EE;'>#trend#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17798, encryptionId=2ebd1e7981a, topicName=trend)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ced3193, createdName=freve, createdTime=Wed Apr 12 01:10:25 CST 2023, time=2023-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1321380, encodeId=49b81321380dc, content=<a href='/topic/show?id=ac0d159007f' target=_blank style='color:#2F92EE;'>#SARS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15900, encryptionId=ac0d159007f, topicName=SARS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8306486, createdName=小刀医生, createdTime=Thu Jul 14 20:10:25 CST 2022, time=2022-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1376481, encodeId=f57d13e648111, content=<a href='/topic/show?id=2949159989d' target=_blank style='color:#2F92EE;'>#SCIE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15998, encryptionId=2949159989d, topicName=SCIE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17a3387, createdName=jichang, createdTime=Thu Jul 14 20:10:25 CST 2022, time=2022-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232187, encodeId=1cb5123218ec9, content=研究结果和对照组相比不存在显著差异。轻度新冠本身症状就轻微,缓解速度快,存在自限性,也已无需住院治疗,再考虑到患者的个体差异(体质、年龄、疫苗接种情况等)该研究结果的临床症状改善并没有说服力。且对于疗效最显著的咽痛也并非新冠最典型、危害最大的评价监测指标,缺乏最关键的发热(退烧)症状的评价结果(临床单用柴胡、板蓝根退烧作用有限),另外,核酸转阴0.5天(12h)是如何精准评价的?有什么现实意义呢?好奇这么漏洞百出的研究结果是怎么被SCI收录的?, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=821f2227826, createdName=DR.Fu SIR, createdTime=Wed Jul 13 09:36:30 CST 2022, time=2022-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232178, encodeId=8e0512321e856, content=认真学习~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cfb41991958, createdName=xulv123, createdTime=Wed Jul 13 08:51:02 CST 2022, time=2022-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232161, encodeId=3547123216120, content=<a href='/topic/show?id=5c1d22423c8' target=_blank style='color:#2F92EE;'>#中药#</a>治疗<a href='/topic/show?id=65b05806579' target=_blank style='color:#2F92EE;'>#新冠病毒#</a>感染, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22423, encryptionId=5c1d22423c8, topicName=中药), TopicDto(id=58065, encryptionId=65b05806579, topicName=新冠病毒)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=小小医者, createdTime=Wed Jul 13 05:25:33 CST 2022, time=2022-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232160, encodeId=8f95123216049, content=这个研究表明,轻中度的<a href='/topic/show?id=8a4e10443423' target=_blank style='color:#2F92EE;'>#奥密克戎#</a>不用药,同样可以治愈。基本是1周,80%自动康复,治疗约5天,不治疗约6-7天就恢复正常了。部分人,可能需要1-2周时间。 用了中药以后,可能略略感觉好一点。 当然,这个研究设计还是漏洞百出,结论也说明不了太多问题,不过,整个数据还是相对可信的。, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104434, encryptionId=8a4e10443423, topicName=奥密克戎)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=小小医者, createdTime=Wed Jul 13 05:25:17 CST 2022, time=2022-07-13, status=1, ipAttribution=)]
    2022-12-05 sunylz
  3. [GetPortalCommentsPageByObjectIdResponse(id=1938109, encodeId=b5b11938109f7, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15902, encryptionId=02de15902d3, topicName=SARS-CoV)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6ab940, createdName=hukaixun, createdTime=Fri Mar 03 20:10:25 CST 2023, time=2023-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1919463, encodeId=29fb1919463e2, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Mon Dec 05 18:10:25 CST 2022, time=2022-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1785300, encodeId=c85a1e8530038, content=<a href='/topic/show?id=51906e79a6' target=_blank style='color:#2F92EE;'>#ENDS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6779, encryptionId=51906e79a6, topicName=ENDS)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82ba2500166, createdName=ms1467340776200723, createdTime=Mon Sep 19 17:10:25 CST 2022, time=2022-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1905728, encodeId=800e1905e2857, content=<a href='/topic/show?id=2ebd1e7981a' target=_blank style='color:#2F92EE;'>#trend#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17798, encryptionId=2ebd1e7981a, topicName=trend)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ced3193, createdName=freve, createdTime=Wed Apr 12 01:10:25 CST 2023, time=2023-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1321380, encodeId=49b81321380dc, content=<a href='/topic/show?id=ac0d159007f' target=_blank style='color:#2F92EE;'>#SARS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15900, encryptionId=ac0d159007f, topicName=SARS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8306486, createdName=小刀医生, createdTime=Thu Jul 14 20:10:25 CST 2022, time=2022-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1376481, encodeId=f57d13e648111, content=<a href='/topic/show?id=2949159989d' target=_blank style='color:#2F92EE;'>#SCIE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15998, encryptionId=2949159989d, topicName=SCIE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17a3387, createdName=jichang, createdTime=Thu Jul 14 20:10:25 CST 2022, time=2022-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232187, encodeId=1cb5123218ec9, content=研究结果和对照组相比不存在显著差异。轻度新冠本身症状就轻微,缓解速度快,存在自限性,也已无需住院治疗,再考虑到患者的个体差异(体质、年龄、疫苗接种情况等)该研究结果的临床症状改善并没有说服力。且对于疗效最显著的咽痛也并非新冠最典型、危害最大的评价监测指标,缺乏最关键的发热(退烧)症状的评价结果(临床单用柴胡、板蓝根退烧作用有限),另外,核酸转阴0.5天(12h)是如何精准评价的?有什么现实意义呢?好奇这么漏洞百出的研究结果是怎么被SCI收录的?, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=821f2227826, createdName=DR.Fu SIR, createdTime=Wed Jul 13 09:36:30 CST 2022, time=2022-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232178, encodeId=8e0512321e856, content=认真学习~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cfb41991958, createdName=xulv123, createdTime=Wed Jul 13 08:51:02 CST 2022, time=2022-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232161, encodeId=3547123216120, content=<a href='/topic/show?id=5c1d22423c8' target=_blank style='color:#2F92EE;'>#中药#</a>治疗<a href='/topic/show?id=65b05806579' target=_blank style='color:#2F92EE;'>#新冠病毒#</a>感染, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22423, encryptionId=5c1d22423c8, topicName=中药), TopicDto(id=58065, encryptionId=65b05806579, topicName=新冠病毒)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=小小医者, createdTime=Wed Jul 13 05:25:33 CST 2022, time=2022-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232160, encodeId=8f95123216049, content=这个研究表明,轻中度的<a href='/topic/show?id=8a4e10443423' target=_blank style='color:#2F92EE;'>#奥密克戎#</a>不用药,同样可以治愈。基本是1周,80%自动康复,治疗约5天,不治疗约6-7天就恢复正常了。部分人,可能需要1-2周时间。 用了中药以后,可能略略感觉好一点。 当然,这个研究设计还是漏洞百出,结论也说明不了太多问题,不过,整个数据还是相对可信的。, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104434, encryptionId=8a4e10443423, topicName=奥密克戎)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=小小医者, createdTime=Wed Jul 13 05:25:17 CST 2022, time=2022-07-13, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1938109, encodeId=b5b11938109f7, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15902, encryptionId=02de15902d3, topicName=SARS-CoV)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6ab940, createdName=hukaixun, createdTime=Fri Mar 03 20:10:25 CST 2023, time=2023-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1919463, encodeId=29fb1919463e2, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Mon Dec 05 18:10:25 CST 2022, time=2022-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1785300, encodeId=c85a1e8530038, content=<a href='/topic/show?id=51906e79a6' target=_blank style='color:#2F92EE;'>#ENDS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6779, encryptionId=51906e79a6, topicName=ENDS)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82ba2500166, createdName=ms1467340776200723, createdTime=Mon Sep 19 17:10:25 CST 2022, time=2022-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1905728, encodeId=800e1905e2857, content=<a href='/topic/show?id=2ebd1e7981a' target=_blank style='color:#2F92EE;'>#trend#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17798, encryptionId=2ebd1e7981a, topicName=trend)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ced3193, createdName=freve, createdTime=Wed Apr 12 01:10:25 CST 2023, time=2023-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1321380, encodeId=49b81321380dc, content=<a href='/topic/show?id=ac0d159007f' target=_blank style='color:#2F92EE;'>#SARS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15900, encryptionId=ac0d159007f, topicName=SARS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8306486, createdName=小刀医生, createdTime=Thu Jul 14 20:10:25 CST 2022, time=2022-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1376481, encodeId=f57d13e648111, content=<a href='/topic/show?id=2949159989d' target=_blank style='color:#2F92EE;'>#SCIE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15998, encryptionId=2949159989d, topicName=SCIE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17a3387, createdName=jichang, createdTime=Thu Jul 14 20:10:25 CST 2022, time=2022-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232187, encodeId=1cb5123218ec9, content=研究结果和对照组相比不存在显著差异。轻度新冠本身症状就轻微,缓解速度快,存在自限性,也已无需住院治疗,再考虑到患者的个体差异(体质、年龄、疫苗接种情况等)该研究结果的临床症状改善并没有说服力。且对于疗效最显著的咽痛也并非新冠最典型、危害最大的评价监测指标,缺乏最关键的发热(退烧)症状的评价结果(临床单用柴胡、板蓝根退烧作用有限),另外,核酸转阴0.5天(12h)是如何精准评价的?有什么现实意义呢?好奇这么漏洞百出的研究结果是怎么被SCI收录的?, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=821f2227826, createdName=DR.Fu SIR, createdTime=Wed Jul 13 09:36:30 CST 2022, time=2022-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232178, encodeId=8e0512321e856, content=认真学习~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cfb41991958, createdName=xulv123, createdTime=Wed Jul 13 08:51:02 CST 2022, time=2022-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232161, encodeId=3547123216120, content=<a href='/topic/show?id=5c1d22423c8' target=_blank style='color:#2F92EE;'>#中药#</a>治疗<a href='/topic/show?id=65b05806579' target=_blank style='color:#2F92EE;'>#新冠病毒#</a>感染, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22423, encryptionId=5c1d22423c8, topicName=中药), TopicDto(id=58065, encryptionId=65b05806579, topicName=新冠病毒)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=小小医者, createdTime=Wed Jul 13 05:25:33 CST 2022, time=2022-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232160, encodeId=8f95123216049, content=这个研究表明,轻中度的<a href='/topic/show?id=8a4e10443423' target=_blank style='color:#2F92EE;'>#奥密克戎#</a>不用药,同样可以治愈。基本是1周,80%自动康复,治疗约5天,不治疗约6-7天就恢复正常了。部分人,可能需要1-2周时间。 用了中药以后,可能略略感觉好一点。 当然,这个研究设计还是漏洞百出,结论也说明不了太多问题,不过,整个数据还是相对可信的。, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104434, encryptionId=8a4e10443423, topicName=奥密克戎)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=小小医者, createdTime=Wed Jul 13 05:25:17 CST 2022, time=2022-07-13, status=1, ipAttribution=)]
    2023-04-12 freve
  5. [GetPortalCommentsPageByObjectIdResponse(id=1938109, encodeId=b5b11938109f7, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15902, encryptionId=02de15902d3, topicName=SARS-CoV)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6ab940, createdName=hukaixun, createdTime=Fri Mar 03 20:10:25 CST 2023, time=2023-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1919463, encodeId=29fb1919463e2, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Mon Dec 05 18:10:25 CST 2022, time=2022-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1785300, encodeId=c85a1e8530038, content=<a href='/topic/show?id=51906e79a6' target=_blank style='color:#2F92EE;'>#ENDS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6779, encryptionId=51906e79a6, topicName=ENDS)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82ba2500166, createdName=ms1467340776200723, createdTime=Mon Sep 19 17:10:25 CST 2022, time=2022-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1905728, encodeId=800e1905e2857, content=<a href='/topic/show?id=2ebd1e7981a' target=_blank style='color:#2F92EE;'>#trend#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17798, encryptionId=2ebd1e7981a, topicName=trend)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ced3193, createdName=freve, createdTime=Wed Apr 12 01:10:25 CST 2023, time=2023-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1321380, encodeId=49b81321380dc, content=<a href='/topic/show?id=ac0d159007f' target=_blank style='color:#2F92EE;'>#SARS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15900, encryptionId=ac0d159007f, topicName=SARS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8306486, createdName=小刀医生, createdTime=Thu Jul 14 20:10:25 CST 2022, time=2022-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1376481, encodeId=f57d13e648111, content=<a href='/topic/show?id=2949159989d' target=_blank style='color:#2F92EE;'>#SCIE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15998, encryptionId=2949159989d, topicName=SCIE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17a3387, createdName=jichang, createdTime=Thu Jul 14 20:10:25 CST 2022, time=2022-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232187, encodeId=1cb5123218ec9, content=研究结果和对照组相比不存在显著差异。轻度新冠本身症状就轻微,缓解速度快,存在自限性,也已无需住院治疗,再考虑到患者的个体差异(体质、年龄、疫苗接种情况等)该研究结果的临床症状改善并没有说服力。且对于疗效最显著的咽痛也并非新冠最典型、危害最大的评价监测指标,缺乏最关键的发热(退烧)症状的评价结果(临床单用柴胡、板蓝根退烧作用有限),另外,核酸转阴0.5天(12h)是如何精准评价的?有什么现实意义呢?好奇这么漏洞百出的研究结果是怎么被SCI收录的?, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=821f2227826, createdName=DR.Fu SIR, createdTime=Wed Jul 13 09:36:30 CST 2022, time=2022-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232178, encodeId=8e0512321e856, content=认真学习~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cfb41991958, createdName=xulv123, createdTime=Wed Jul 13 08:51:02 CST 2022, time=2022-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232161, encodeId=3547123216120, content=<a href='/topic/show?id=5c1d22423c8' target=_blank style='color:#2F92EE;'>#中药#</a>治疗<a href='/topic/show?id=65b05806579' target=_blank style='color:#2F92EE;'>#新冠病毒#</a>感染, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22423, encryptionId=5c1d22423c8, topicName=中药), TopicDto(id=58065, encryptionId=65b05806579, topicName=新冠病毒)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=小小医者, createdTime=Wed Jul 13 05:25:33 CST 2022, time=2022-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232160, encodeId=8f95123216049, content=这个研究表明,轻中度的<a href='/topic/show?id=8a4e10443423' target=_blank style='color:#2F92EE;'>#奥密克戎#</a>不用药,同样可以治愈。基本是1周,80%自动康复,治疗约5天,不治疗约6-7天就恢复正常了。部分人,可能需要1-2周时间。 用了中药以后,可能略略感觉好一点。 当然,这个研究设计还是漏洞百出,结论也说明不了太多问题,不过,整个数据还是相对可信的。, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104434, encryptionId=8a4e10443423, topicName=奥密克戎)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=小小医者, createdTime=Wed Jul 13 05:25:17 CST 2022, time=2022-07-13, status=1, ipAttribution=)]
    2022-07-14 小刀医生
  6. [GetPortalCommentsPageByObjectIdResponse(id=1938109, encodeId=b5b11938109f7, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15902, encryptionId=02de15902d3, topicName=SARS-CoV)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6ab940, createdName=hukaixun, createdTime=Fri Mar 03 20:10:25 CST 2023, time=2023-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1919463, encodeId=29fb1919463e2, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Mon Dec 05 18:10:25 CST 2022, time=2022-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1785300, encodeId=c85a1e8530038, content=<a href='/topic/show?id=51906e79a6' target=_blank style='color:#2F92EE;'>#ENDS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6779, encryptionId=51906e79a6, topicName=ENDS)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82ba2500166, createdName=ms1467340776200723, createdTime=Mon Sep 19 17:10:25 CST 2022, time=2022-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1905728, encodeId=800e1905e2857, content=<a href='/topic/show?id=2ebd1e7981a' target=_blank style='color:#2F92EE;'>#trend#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17798, encryptionId=2ebd1e7981a, topicName=trend)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ced3193, createdName=freve, createdTime=Wed Apr 12 01:10:25 CST 2023, time=2023-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1321380, encodeId=49b81321380dc, content=<a href='/topic/show?id=ac0d159007f' target=_blank style='color:#2F92EE;'>#SARS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15900, encryptionId=ac0d159007f, topicName=SARS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8306486, createdName=小刀医生, createdTime=Thu Jul 14 20:10:25 CST 2022, time=2022-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1376481, encodeId=f57d13e648111, content=<a href='/topic/show?id=2949159989d' target=_blank style='color:#2F92EE;'>#SCIE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15998, encryptionId=2949159989d, topicName=SCIE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17a3387, createdName=jichang, createdTime=Thu Jul 14 20:10:25 CST 2022, time=2022-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232187, encodeId=1cb5123218ec9, content=研究结果和对照组相比不存在显著差异。轻度新冠本身症状就轻微,缓解速度快,存在自限性,也已无需住院治疗,再考虑到患者的个体差异(体质、年龄、疫苗接种情况等)该研究结果的临床症状改善并没有说服力。且对于疗效最显著的咽痛也并非新冠最典型、危害最大的评价监测指标,缺乏最关键的发热(退烧)症状的评价结果(临床单用柴胡、板蓝根退烧作用有限),另外,核酸转阴0.5天(12h)是如何精准评价的?有什么现实意义呢?好奇这么漏洞百出的研究结果是怎么被SCI收录的?, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=821f2227826, createdName=DR.Fu SIR, createdTime=Wed Jul 13 09:36:30 CST 2022, time=2022-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232178, encodeId=8e0512321e856, content=认真学习~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cfb41991958, createdName=xulv123, createdTime=Wed Jul 13 08:51:02 CST 2022, time=2022-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232161, encodeId=3547123216120, content=<a href='/topic/show?id=5c1d22423c8' target=_blank style='color:#2F92EE;'>#中药#</a>治疗<a href='/topic/show?id=65b05806579' target=_blank style='color:#2F92EE;'>#新冠病毒#</a>感染, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22423, encryptionId=5c1d22423c8, topicName=中药), TopicDto(id=58065, encryptionId=65b05806579, topicName=新冠病毒)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=小小医者, createdTime=Wed Jul 13 05:25:33 CST 2022, time=2022-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232160, encodeId=8f95123216049, content=这个研究表明,轻中度的<a href='/topic/show?id=8a4e10443423' target=_blank style='color:#2F92EE;'>#奥密克戎#</a>不用药,同样可以治愈。基本是1周,80%自动康复,治疗约5天,不治疗约6-7天就恢复正常了。部分人,可能需要1-2周时间。 用了中药以后,可能略略感觉好一点。 当然,这个研究设计还是漏洞百出,结论也说明不了太多问题,不过,整个数据还是相对可信的。, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104434, encryptionId=8a4e10443423, topicName=奥密克戎)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=小小医者, createdTime=Wed Jul 13 05:25:17 CST 2022, time=2022-07-13, status=1, ipAttribution=)]
    2022-07-14 jichang
  7. [GetPortalCommentsPageByObjectIdResponse(id=1938109, encodeId=b5b11938109f7, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15902, encryptionId=02de15902d3, topicName=SARS-CoV)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6ab940, createdName=hukaixun, createdTime=Fri Mar 03 20:10:25 CST 2023, time=2023-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1919463, encodeId=29fb1919463e2, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Mon Dec 05 18:10:25 CST 2022, time=2022-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1785300, encodeId=c85a1e8530038, content=<a href='/topic/show?id=51906e79a6' target=_blank style='color:#2F92EE;'>#ENDS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6779, encryptionId=51906e79a6, topicName=ENDS)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82ba2500166, createdName=ms1467340776200723, createdTime=Mon Sep 19 17:10:25 CST 2022, time=2022-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1905728, encodeId=800e1905e2857, content=<a href='/topic/show?id=2ebd1e7981a' target=_blank style='color:#2F92EE;'>#trend#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17798, encryptionId=2ebd1e7981a, topicName=trend)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ced3193, createdName=freve, createdTime=Wed Apr 12 01:10:25 CST 2023, time=2023-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1321380, encodeId=49b81321380dc, content=<a href='/topic/show?id=ac0d159007f' target=_blank style='color:#2F92EE;'>#SARS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15900, encryptionId=ac0d159007f, topicName=SARS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8306486, createdName=小刀医生, createdTime=Thu Jul 14 20:10:25 CST 2022, time=2022-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1376481, encodeId=f57d13e648111, content=<a href='/topic/show?id=2949159989d' target=_blank style='color:#2F92EE;'>#SCIE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15998, encryptionId=2949159989d, topicName=SCIE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17a3387, createdName=jichang, createdTime=Thu Jul 14 20:10:25 CST 2022, time=2022-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232187, encodeId=1cb5123218ec9, content=研究结果和对照组相比不存在显著差异。轻度新冠本身症状就轻微,缓解速度快,存在自限性,也已无需住院治疗,再考虑到患者的个体差异(体质、年龄、疫苗接种情况等)该研究结果的临床症状改善并没有说服力。且对于疗效最显著的咽痛也并非新冠最典型、危害最大的评价监测指标,缺乏最关键的发热(退烧)症状的评价结果(临床单用柴胡、板蓝根退烧作用有限),另外,核酸转阴0.5天(12h)是如何精准评价的?有什么现实意义呢?好奇这么漏洞百出的研究结果是怎么被SCI收录的?, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=821f2227826, createdName=DR.Fu SIR, createdTime=Wed Jul 13 09:36:30 CST 2022, time=2022-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232178, encodeId=8e0512321e856, content=认真学习~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cfb41991958, createdName=xulv123, createdTime=Wed Jul 13 08:51:02 CST 2022, time=2022-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232161, encodeId=3547123216120, content=<a href='/topic/show?id=5c1d22423c8' target=_blank style='color:#2F92EE;'>#中药#</a>治疗<a href='/topic/show?id=65b05806579' target=_blank style='color:#2F92EE;'>#新冠病毒#</a>感染, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22423, encryptionId=5c1d22423c8, topicName=中药), TopicDto(id=58065, encryptionId=65b05806579, topicName=新冠病毒)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=小小医者, createdTime=Wed Jul 13 05:25:33 CST 2022, time=2022-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232160, encodeId=8f95123216049, content=这个研究表明,轻中度的<a href='/topic/show?id=8a4e10443423' target=_blank style='color:#2F92EE;'>#奥密克戎#</a>不用药,同样可以治愈。基本是1周,80%自动康复,治疗约5天,不治疗约6-7天就恢复正常了。部分人,可能需要1-2周时间。 用了中药以后,可能略略感觉好一点。 当然,这个研究设计还是漏洞百出,结论也说明不了太多问题,不过,整个数据还是相对可信的。, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104434, encryptionId=8a4e10443423, topicName=奥密克戎)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=小小医者, createdTime=Wed Jul 13 05:25:17 CST 2022, time=2022-07-13, status=1, ipAttribution=)]
    2022-07-13 DR.Fu SIR

    研究结果和对照组相比不存在显著差异。轻度新冠本身症状就轻微,缓解速度快,存在自限性,也已无需住院治疗,再考虑到患者的个体差异(体质、年龄、疫苗接种情况等)该研究结果的临床症状改善并没有说服力。且对于疗效最显著的咽痛也并非新冠最典型、危害最大的评价监测指标,缺乏最关键的发热(退烧)症状的评价结果(临床单用柴胡、板蓝根退烧作用有限),另外,核酸转阴0.5天(12h)是如何精准评价的?有什么现实意义呢?好奇这么漏洞百出的研究结果是怎么被SCI收录的?

    2

    展开2条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=1938109, encodeId=b5b11938109f7, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15902, encryptionId=02de15902d3, topicName=SARS-CoV)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6ab940, createdName=hukaixun, createdTime=Fri Mar 03 20:10:25 CST 2023, time=2023-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1919463, encodeId=29fb1919463e2, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Mon Dec 05 18:10:25 CST 2022, time=2022-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1785300, encodeId=c85a1e8530038, content=<a href='/topic/show?id=51906e79a6' target=_blank style='color:#2F92EE;'>#ENDS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6779, encryptionId=51906e79a6, topicName=ENDS)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82ba2500166, createdName=ms1467340776200723, createdTime=Mon Sep 19 17:10:25 CST 2022, time=2022-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1905728, encodeId=800e1905e2857, content=<a href='/topic/show?id=2ebd1e7981a' target=_blank style='color:#2F92EE;'>#trend#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17798, encryptionId=2ebd1e7981a, topicName=trend)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ced3193, createdName=freve, createdTime=Wed Apr 12 01:10:25 CST 2023, time=2023-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1321380, encodeId=49b81321380dc, content=<a href='/topic/show?id=ac0d159007f' target=_blank style='color:#2F92EE;'>#SARS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15900, encryptionId=ac0d159007f, topicName=SARS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8306486, createdName=小刀医生, createdTime=Thu Jul 14 20:10:25 CST 2022, time=2022-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1376481, encodeId=f57d13e648111, content=<a href='/topic/show?id=2949159989d' target=_blank style='color:#2F92EE;'>#SCIE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15998, encryptionId=2949159989d, topicName=SCIE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17a3387, createdName=jichang, createdTime=Thu Jul 14 20:10:25 CST 2022, time=2022-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232187, encodeId=1cb5123218ec9, content=研究结果和对照组相比不存在显著差异。轻度新冠本身症状就轻微,缓解速度快,存在自限性,也已无需住院治疗,再考虑到患者的个体差异(体质、年龄、疫苗接种情况等)该研究结果的临床症状改善并没有说服力。且对于疗效最显著的咽痛也并非新冠最典型、危害最大的评价监测指标,缺乏最关键的发热(退烧)症状的评价结果(临床单用柴胡、板蓝根退烧作用有限),另外,核酸转阴0.5天(12h)是如何精准评价的?有什么现实意义呢?好奇这么漏洞百出的研究结果是怎么被SCI收录的?, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=821f2227826, createdName=DR.Fu SIR, createdTime=Wed Jul 13 09:36:30 CST 2022, time=2022-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232178, encodeId=8e0512321e856, content=认真学习~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cfb41991958, createdName=xulv123, createdTime=Wed Jul 13 08:51:02 CST 2022, time=2022-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232161, encodeId=3547123216120, content=<a href='/topic/show?id=5c1d22423c8' target=_blank style='color:#2F92EE;'>#中药#</a>治疗<a href='/topic/show?id=65b05806579' target=_blank style='color:#2F92EE;'>#新冠病毒#</a>感染, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22423, encryptionId=5c1d22423c8, topicName=中药), TopicDto(id=58065, encryptionId=65b05806579, topicName=新冠病毒)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=小小医者, createdTime=Wed Jul 13 05:25:33 CST 2022, time=2022-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232160, encodeId=8f95123216049, content=这个研究表明,轻中度的<a href='/topic/show?id=8a4e10443423' target=_blank style='color:#2F92EE;'>#奥密克戎#</a>不用药,同样可以治愈。基本是1周,80%自动康复,治疗约5天,不治疗约6-7天就恢复正常了。部分人,可能需要1-2周时间。 用了中药以后,可能略略感觉好一点。 当然,这个研究设计还是漏洞百出,结论也说明不了太多问题,不过,整个数据还是相对可信的。, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104434, encryptionId=8a4e10443423, topicName=奥密克戎)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=小小医者, createdTime=Wed Jul 13 05:25:17 CST 2022, time=2022-07-13, status=1, ipAttribution=)]
    2022-07-13 xulv123

    认真学习~~

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=1938109, encodeId=b5b11938109f7, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15902, encryptionId=02de15902d3, topicName=SARS-CoV)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6ab940, createdName=hukaixun, createdTime=Fri Mar 03 20:10:25 CST 2023, time=2023-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1919463, encodeId=29fb1919463e2, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Mon Dec 05 18:10:25 CST 2022, time=2022-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1785300, encodeId=c85a1e8530038, content=<a href='/topic/show?id=51906e79a6' target=_blank style='color:#2F92EE;'>#ENDS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6779, encryptionId=51906e79a6, topicName=ENDS)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82ba2500166, createdName=ms1467340776200723, createdTime=Mon Sep 19 17:10:25 CST 2022, time=2022-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1905728, encodeId=800e1905e2857, content=<a href='/topic/show?id=2ebd1e7981a' target=_blank style='color:#2F92EE;'>#trend#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17798, encryptionId=2ebd1e7981a, topicName=trend)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ced3193, createdName=freve, createdTime=Wed Apr 12 01:10:25 CST 2023, time=2023-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1321380, encodeId=49b81321380dc, content=<a href='/topic/show?id=ac0d159007f' target=_blank style='color:#2F92EE;'>#SARS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15900, encryptionId=ac0d159007f, topicName=SARS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8306486, createdName=小刀医生, createdTime=Thu Jul 14 20:10:25 CST 2022, time=2022-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1376481, encodeId=f57d13e648111, content=<a href='/topic/show?id=2949159989d' target=_blank style='color:#2F92EE;'>#SCIE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15998, encryptionId=2949159989d, topicName=SCIE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17a3387, createdName=jichang, createdTime=Thu Jul 14 20:10:25 CST 2022, time=2022-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232187, encodeId=1cb5123218ec9, content=研究结果和对照组相比不存在显著差异。轻度新冠本身症状就轻微,缓解速度快,存在自限性,也已无需住院治疗,再考虑到患者的个体差异(体质、年龄、疫苗接种情况等)该研究结果的临床症状改善并没有说服力。且对于疗效最显著的咽痛也并非新冠最典型、危害最大的评价监测指标,缺乏最关键的发热(退烧)症状的评价结果(临床单用柴胡、板蓝根退烧作用有限),另外,核酸转阴0.5天(12h)是如何精准评价的?有什么现实意义呢?好奇这么漏洞百出的研究结果是怎么被SCI收录的?, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=821f2227826, createdName=DR.Fu SIR, createdTime=Wed Jul 13 09:36:30 CST 2022, time=2022-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232178, encodeId=8e0512321e856, content=认真学习~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cfb41991958, createdName=xulv123, createdTime=Wed Jul 13 08:51:02 CST 2022, time=2022-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232161, encodeId=3547123216120, content=<a href='/topic/show?id=5c1d22423c8' target=_blank style='color:#2F92EE;'>#中药#</a>治疗<a href='/topic/show?id=65b05806579' target=_blank style='color:#2F92EE;'>#新冠病毒#</a>感染, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22423, encryptionId=5c1d22423c8, topicName=中药), TopicDto(id=58065, encryptionId=65b05806579, topicName=新冠病毒)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=小小医者, createdTime=Wed Jul 13 05:25:33 CST 2022, time=2022-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232160, encodeId=8f95123216049, content=这个研究表明,轻中度的<a href='/topic/show?id=8a4e10443423' target=_blank style='color:#2F92EE;'>#奥密克戎#</a>不用药,同样可以治愈。基本是1周,80%自动康复,治疗约5天,不治疗约6-7天就恢复正常了。部分人,可能需要1-2周时间。 用了中药以后,可能略略感觉好一点。 当然,这个研究设计还是漏洞百出,结论也说明不了太多问题,不过,整个数据还是相对可信的。, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104434, encryptionId=8a4e10443423, topicName=奥密克戎)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=小小医者, createdTime=Wed Jul 13 05:25:17 CST 2022, time=2022-07-13, status=1, ipAttribution=)]
    2022-07-13 小小医者
  10. [GetPortalCommentsPageByObjectIdResponse(id=1938109, encodeId=b5b11938109f7, content=<a href='/topic/show?id=02de15902d3' target=_blank style='color:#2F92EE;'>#SARS-CoV#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15902, encryptionId=02de15902d3, topicName=SARS-CoV)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6ab940, createdName=hukaixun, createdTime=Fri Mar 03 20:10:25 CST 2023, time=2023-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1919463, encodeId=29fb1919463e2, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Mon Dec 05 18:10:25 CST 2022, time=2022-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1785300, encodeId=c85a1e8530038, content=<a href='/topic/show?id=51906e79a6' target=_blank style='color:#2F92EE;'>#ENDS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6779, encryptionId=51906e79a6, topicName=ENDS)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=82ba2500166, createdName=ms1467340776200723, createdTime=Mon Sep 19 17:10:25 CST 2022, time=2022-09-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1905728, encodeId=800e1905e2857, content=<a href='/topic/show?id=2ebd1e7981a' target=_blank style='color:#2F92EE;'>#trend#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17798, encryptionId=2ebd1e7981a, topicName=trend)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ced3193, createdName=freve, createdTime=Wed Apr 12 01:10:25 CST 2023, time=2023-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1321380, encodeId=49b81321380dc, content=<a href='/topic/show?id=ac0d159007f' target=_blank style='color:#2F92EE;'>#SARS#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15900, encryptionId=ac0d159007f, topicName=SARS)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8306486, createdName=小刀医生, createdTime=Thu Jul 14 20:10:25 CST 2022, time=2022-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1376481, encodeId=f57d13e648111, content=<a href='/topic/show?id=2949159989d' target=_blank style='color:#2F92EE;'>#SCIE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15998, encryptionId=2949159989d, topicName=SCIE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17a3387, createdName=jichang, createdTime=Thu Jul 14 20:10:25 CST 2022, time=2022-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232187, encodeId=1cb5123218ec9, content=研究结果和对照组相比不存在显著差异。轻度新冠本身症状就轻微,缓解速度快,存在自限性,也已无需住院治疗,再考虑到患者的个体差异(体质、年龄、疫苗接种情况等)该研究结果的临床症状改善并没有说服力。且对于疗效最显著的咽痛也并非新冠最典型、危害最大的评价监测指标,缺乏最关键的发热(退烧)症状的评价结果(临床单用柴胡、板蓝根退烧作用有限),另外,核酸转阴0.5天(12h)是如何精准评价的?有什么现实意义呢?好奇这么漏洞百出的研究结果是怎么被SCI收录的?, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=821f2227826, createdName=DR.Fu SIR, createdTime=Wed Jul 13 09:36:30 CST 2022, time=2022-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232178, encodeId=8e0512321e856, content=认真学习~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cfb41991958, createdName=xulv123, createdTime=Wed Jul 13 08:51:02 CST 2022, time=2022-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232161, encodeId=3547123216120, content=<a href='/topic/show?id=5c1d22423c8' target=_blank style='color:#2F92EE;'>#中药#</a>治疗<a href='/topic/show?id=65b05806579' target=_blank style='color:#2F92EE;'>#新冠病毒#</a>感染, beContent=null, objectType=article, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=22423, encryptionId=5c1d22423c8, topicName=中药), TopicDto(id=58065, encryptionId=65b05806579, topicName=新冠病毒)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=小小医者, createdTime=Wed Jul 13 05:25:33 CST 2022, time=2022-07-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232160, encodeId=8f95123216049, content=这个研究表明,轻中度的<a href='/topic/show?id=8a4e10443423' target=_blank style='color:#2F92EE;'>#奥密克戎#</a>不用药,同样可以治愈。基本是1周,80%自动康复,治疗约5天,不治疗约6-7天就恢复正常了。部分人,可能需要1-2周时间。 用了中药以后,可能略略感觉好一点。 当然,这个研究设计还是漏洞百出,结论也说明不了太多问题,不过,整个数据还是相对可信的。, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=104434, encryptionId=8a4e10443423, topicName=奥密克戎)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=小小医者, createdTime=Wed Jul 13 05:25:17 CST 2022, time=2022-07-13, status=1, ipAttribution=)]
    2022-07-13 小小医者

    这个研究表明,轻中度的#奥密克戎#不用药,同样可以治愈。基本是1周,80%自动康复,治疗约5天,不治疗约6-7天就恢复正常了。部分人,可能需要1-2周时间。 用了中药以后,可能略略感觉好一点。 当然,这个研究设计还是漏洞百出,结论也说明不了太多问题,不过,整个数据还是相对可信的。

    0

相关资讯

STTT:中药天然化合物治疗缺血性脑卒中

中风与人类疾病中的第二大死亡原因和第三大残疾原因有关,而 IS 特别占所有中风病例的 80% 以上。由于人口的快速增长和老龄化,IS 发病率随着年龄的增长而急剧增加。

Front Pharmacol:益生菌联合中药治疗溃疡性结肠炎的疗效和安全性

益生菌联合中药(TCM)是治疗溃疡性结肠炎(UC)的一种前瞻性疗法,其疗效和安全性亟待评估。

J Ethnopharmacol:年龄相关性黄斑变性不可忽视的中医治疗选择

年龄相关性黄斑变性 (AMD) 是一种慢性神经退行性疾病,可导致老年人群中不可逆的中心视力丧失。传统中药 (TCM),包括方剂、针灸和草药,已用于治疗 AMD 已有数千年的历史。

Front Pharmacol:中医药治疗阿尔茨海默病合并骨质疏松症的广阔前景

阿尔茨海默病和骨质疏松症是由多种因素引起的进行性退行性疾病,给世界带来了巨大的负担。大量证据表明 OP 是 AD 患者的常见并发症。

J Integr Med:中草药治疗老年便秘,似乎效果更佳

便秘是一种常见的慢性肠道疾病,在老年人口中的发病率超过50%。补充和替代药物是一种成本效益高且令人满意的治疗便秘的方法,被老年人广泛使用。

Pharmacol Res:中医药在脑出血病理生理过程中的应用

脑出血(Intracebral hemorrhage,ICH)是第二常见的卒中亚型,具有高发病率、残疾和死亡率。